Skip to content

Dietary Intervention Study for Adult Asthmatics

Dietary Intervention Study for Adult Asthmatics - Asthma Diet Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000054043
Enrollment
30
Registered
2024-05-30
Start date
2024-08-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

Patients will receive dietary intervention based on the specific suggestions of the dietitian for 4 weeks from the start of the intervention
the strict dietary intervention period. Recipes supervised by a dietitian from Oishi-Kenko will be proposed to the patients based on nutritional guidance for obesity, diabetes, dyslipidemia, and hype
taking tree nuts/soy products. Send a daily evaluation of their ability to follow the suggested diet to the dietitian and receive feedback and guidance from the dietitian. The diet during the perio
which is assumed to be approximately 30% of the 4-week period of the strict diet intervention period. After the 4-week period, it is not mandatory to practice the eating behaviors proposed during the

Sponsors

Keio University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who have been diagnosed with bronchial asthma in the past, are able to visit Keio University Hospital, and meet one of the following criteria Obesity with a BMI of 25 or more Type 2 diabetes with HbA1c less than 8%. Dyslipidemia Hyperuricemia The above conditions do not require the applicant to be a patient at Keio University hospital. If the patient has an outpatient clinic, obtain verbal consent from the attending physician.

Exclusion criteria

Exclusion criteria: Pregnant or lactating mothers Chronic kidney disease Grade 3a or higher or renal failure with eGFR less than 59 ml/min/1.73m2 Type 1 diabetes mellitus, type 2 diabetes mellitus on insulin, or type 2 diabetes mellitus with HbA1c of 8% or higher Patients with hypertension that is judged to be poorly controlled by the clinician Other conditions for which the clinician determines that the diet recommended in this study may be associated with exacerbation of the underlying disease Those who cannot give their consent to participate in the study. Those who have difficulty using the contents of the Oishii Kenko App

Design outcomes

Primary

MeasureTime frame
Change in AQLQ (Asthma Quality of Life Questionnaire) from baseline after 4 weeks of dietary intervention

Secondary

MeasureTime frame
Changes in weight and body composition assessment using InBody at the start of the dietary intervention (0 weeks), 4 weeks, and 8 weeks The following questionnaire items at the start of dietary intervention (week 0), 2, 4, and 8 weeks Self-assessment of compliance with nutritional guidance Dietary survey including frequency of consumption of fermented foods, etc. Asthma control (ACQ-5) Asthma Quality of Life Questionnaire (AQLQ) Gastroesophageal reflux symptoms (FSSG) Depression and anxiety (HADS) Questionnaire items of the following items at the start of the dietary intervention (week 0) and at week 8 Nutritional Questionnaire prepared by the National Institute of Biomedical Innovation, National Institute of Health and Nutrition (Questionnaire used for analysis of intestinal bacteria) Questionnaire prepared by the National Institute of Biomedical Innovation and Nutrition (Questionnaire used for analysis of intestinal bacteria) The following laboratory indices at the start of the dietary intervention (week 0), at 4 weeks, and at 8 weeks: Blood samples: (peripheral blood, fractionated), TARC, inhaled antigen-specific IgE, total IgE) LDL-C, HDL-C, lipoprotein, triglycerides, HbA1c, insulin, C-peptide, uric acid, zinc Respiratory function tests: spirometry-assessed lung air volume fraction, effort lung capacity Respiratory function tests: respiratory resistance evaluated by spirometry, respiratory reactance Exhaled nitric oxide concentration (FeNO)

Countries

Japan

Contacts

Public ContactKatsunori Masaki

Keio University School of Medicine Division of Pulmonary Medicine, Department of Medicine

masakik@keio.jp+81333531211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026